GILEAD SCIENCES, INC.
CIK 0000882095
Annualised vol
20.816434%
Beta
0.167753
HHI
4447.065598
Top-10 weight
100.0%
VaR 95%
1.941507%
VaR 99%
4.542729%
Max drawdown
53.085838%
Matched value
100.0%
Returns of reported holdings
Loading returns…
Position changes vs prior quarter
What the latest 13F shows bought and sold against the quarter before, by share count.
Holdings (latest quarter)
| Ticker | Change | Issuer | Class | CUSIP | Value ($) | Weight % | Shares |
|---|---|---|---|---|---|---|---|
| RCUS | UNCHANGED | Arcus Biosciences Inc. | COM | 03969F109 | 968,825,351 | 58.76 | 3.142476E7 |
| LKFT | NEW | Lakefront Biotherapeutics | SPON ADR | 36315X101 | 500,157,715 | 30.34 | 1.6707477E7 |
| ASMB | ADDED | Assembly Biosciences Inc. | COM NEW | 045396207 | 136,770,406 | 8.3 | 4977089.0 |
| KYTX | UNCHANGED | Kyverna Therapeutics Inc. | COM | 501976104 | 36,763,720 | 2.23 | 4126119.0 |
| XLO | UNCHANGED | Xilio Therapeutics Inc. | COM | 98422T100 | 6,230,727 | 0.38 | 650389.0 |
Quarterly portfolios
| Period | Filed | Value ($) | Positions | Vol % | Beta | Max DD % |
|---|---|---|---|---|---|---|
| 2026-06-30 | 2026-08-03 | 1,648,747,919 | 5 | 20.816434 | 0.167753 | 53.085838 |
| 2026-03-31 | 2026-05-08 | 2,117,784,504 | 6 | 10.621406 | 0.08257 | 28.551198 |
| 2025-12-31 | 2026-02-12 | 1,935,507,854 | 6 | 12.918743 | 0.10084 | 33.881588 |
| 2025-09-30 | 2025-11-13 | 1,791,467,184 | 9 | 8.631662 | 0.069208 | 25.677339 |
| 2025-03-31 | 2025-05-13 | 1,181,331,731 | 14 | 6.838176 | 0.052838 | 19.380489 |
| 2024-12-31 | 2025-02-13 | 1,551,148,266 | 16 | 9.413687 | 0.072159 | 26.115852 |